Dr. Donald C. Simonson, M.D., M.B.A., M.P.H., Sc.D.
Executive Vice President of Phase V Technologies, Inc.
Dr. Simonson is a member of the Section of Diabetes and Metabolism at Brigham and Women's Hospital and Lecturer, Harvard Medical School.
Dr. Simonson received his B.A. and M.D. degrees from Yale University. Between 1996 and 2002 Dr. Simonson received an M.B.A. from MIT specializing in health care systems, an M.P.H. in Health Policy and a Sc.D. in Epidemiology from the Harvard School of Public Health (HSPH). From 2002 to 2006 in addition to conducting health outcomes and clinical physiology research in diabetes he also earned an Sc.D. in Epidemiology from HSPH. His dissertation work focused on the analysis of large clinical patient information systems for the evaluation of drug safety.
After an internship and residency in Internal Medicine at Georgetown University Hospital, he returned to Yale in 1980 for a postdoctoral fellowship in Endocrinology and Metabolism. He joined the faculty of Yale University School of Medicine in 1983 to pursue his research interest in the pathophysiology and treatment of diabetes. In 1987, he became Head of the Section on Clinical Physiology at the Joslin Diabetes Center, and was later named Associate Professor and Chief of Diabetes and Metabolism at Brigham and Women's Hospital. He left his paid position at Harvard to pursue training in business, health policy and epidemiology. Dr. Simonson has authored over 100 scientific publications on clinical pathophysiology, complications, and new forms of treatment for diabetes and related metabolic disorders. Dr. Simonson's teaches ID 265 "Practice of Quantitative Methods" and HPM 530 "Measuring and Analyzing the Outcomes of Health Care" as part of the MPH Program at HSPH. As Executive Vice President, he serves primarily in a business advisory and scientific consulting role in the areas of strategic planning and management, outcomes research, health economics, drug safety surveillance and quality performance monitoring.